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It is very important to study the factors affecting the incidence, progress 
and prognosis of patients with vascular dementia. 50 cases of severe middle 
cerebral artery stenosis or occlusion underwent endovascular treatment 
(25 cases of mild cognitive dysfunction, 25 cases of moderate cognitive 
dysfunction) were divided into two groups, where a medical drug treatment 
group and a control group established with 25 cases in each group. The 
cognitive function of each group of patients was evaluated before operation, 
7 days after operation, 30 days after operation, and 180 days after 
operation. CTP was used to compare the hemodynamic changes in patients 
before and after operation. The severe stenosis or occlusion of the middle 
cerebral artery in patients can be improved, and the intracranial blood 
supply of patients with poorly compensated medial cranial circulation and 
hypoperfusion can be restored to a certain extent. Meanwhile, improvement 
of cognitive function was definitive in some patients with cognitive 
dysfunction. To guide the formulation of treatment plans for patients with 
severe middle cerebral artery stenosis or occlusion.
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In recent years, vascular cognitive dysfunction has 
become the second most common cause of Alzheimer's 
disease in China, and the incidence is only lower than 
Alzheimer's disease. Non-dementia vascular cognitive 
dysfunction refers to early or mild cognitive impairment 
caused by cerebrovascular injury, and does not necessar-
ily progress to vascular dementia; if it can be diagnosed 
and treated early in the VCIND stage, the course of the 
disease may reverse. Intracranial artery stenosis is closely 
related to the incidence of cognitive dysfunction, and end-
ovascular treatment can better improve cerebral ischemia. 
The middle cerebral artery mainly supplies blood to the 
temporal lobe, parietal lobe and basal nucleus of the brain. 
The more severe the stenosis of the middle cerebral artery 
segment, the higher the degree of cognitive impairment. 
Insufficient cerebral perfusion may be an important cause 
of cognitive impairment in patients with cerebral artery 
stenosis [1]. The mechanism of cognitive dysfunction 
caused by cerebral hypoperfusion may include: long-term 
ischemia leading to chronic cerebral ischemia, hypoxia, 
and anaerobic glycolysis, which induces phosphorous 
metabolism disorders in the brain hippocampal neuron 
membrane, producing excessive free radicals and releas-
ing a large amount of excitatory amino acids, leading to 
intracellular calcium ion overload and other problems, 
resulting in hippocampus neurotransmitter disorder and 
neuron loss, causing cognitive impairment; white matter 
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lesions are independent risk factors for cognitive dysfunc-
tion, long-term chronic ischemia and hypoxia can lead to 
diffuse demyelination changes in the white matter of the 
brain and accelerate cognitive decline; cerebral ischemia 
and hypoxia promote the production of β-amyloid, accel-
erate the aging and apoptosis of nerve cells, and lead to 
the decline of cognitive function. In addition, decreased 
cerebrovascular reserve capacity is also related to declined 
cognitive function. The pathogenesis of VCI is more com-
plicated and the incidence is high. The incidence of VCI 
is increasing year by year, and the cost of treatment is 
relatively high. However, it is currently the only cognitive 
impairment disease that can be intervened. Recanalization 
of blood vessels may restore blood supply to brain tissue, 
and patients with severe stenosis or occlusion of the mid-




50 patients with severe stenosis or occlusion of the 
middle cerebral artery (25 cases with mild cognitive im-
pairment, 25 cases with moderate cognitive impairment) 
and 50 patients who received internal medications, hos-
pitalized in provincial Grade III Level A hospitals from 
January 2019 to April 2020 were selected.
2.2	Methods
From January 2019 to April 2020, 25 patients with mild 
to moderate cognitive impairment with severe stenosis 
or occlusion of one middle cerebral artery were included. 
The group receiving endovascular treatment was assigned 
as treatment group and the group receiving non-endovas-
cular treatment was assigned as control group. CTP in-
spection was conducted. Inclusion criteria: ① Diagnosed 
with mild to moderate cognitive dysfunction by Montreal 
Cognitive Assessment (MOCA) screening (MOCA score 
<26 points); ② DSA showed severe unilateral middle cer-
ebral artery stenosis or occlusion; ③ Indications for end-
ovascular treatment. Exclusion criteria: ① Have a history 
of dementia and psychiatric diseases; ② Severe middle 
cerebral artery stenosis or occlusion causes blood supply 
area infarction; ③ Severe systemic diseases or neurolog-
ical deficits such as severe aphasia, unable to cooperate 
with cognitive function examination; History of alcohol, 
drug abuse, and psychotic drug abuse.
2.3	Examination	Methods	and	Standards
With the subject’s consent and cooperation, the Mon-
treal Cognitive Assessment (MoCA) was used to evaluate 
and diagnose the subject’s cognitive function. The assess-
ment was arranged to take place in a quiet room whenever 
possible, and an experienced and professionally trained 
neurorehabilitation physician was appointed to conduct 
the assessment and record the assessment score. MOCA 
was conducted 1 week before operation, 7 days after 
operation, 3 months and 6 months after operation on the 
treatment group and control group during the same period. 
The MOCA scoring of cognitive function was evaluated 
by senior neurologists. The total score of MOCA score 
is 30 points. If the score is less than 26, it is considered 
that there is cognitive dysfunction. If number of years 
of education is less than 12 years, 1 point is added to the 
original score. Meanwhile, ReHo analysis was applied to 
the preprocessed resting state functional magnetic reso-
nance imaging (MRI) data, and the data analysis was per-
formed with the brain function data processing software 
developed by Beijing Normal University. Calculation was 
performed until each voxel of the whole brain reached 
consistency in time series with its 26 neighboring voxels 
in the surrounding. In the CTP examination, a CT scanner 
was used to determine cerebral blood flow (CBF), cerebral 
blood volume (CBV), mean transit time (MTT) and peak 
time (TTP), and then the CBF ratio (rCBF) of the affected 
side to the healthy side, CBV ratio (rCBV), MTT differ-
ence (dMTT) and TTP difference (dTTP) were calculated 
respectively.
2.4	Statistical	Analysis
SPSS statistical analysis software was used. The meas-
urement data are expressed as x±s. The independent sam-
ple t-test was used for comparison between the treatment 
group and the control group, and P<0.05 was considered 
as statistically significant.
3.	Results
（1）Comparison of Treatment Efficacy
Table	1. Comparison of Treatment Efficacy
Group






[Cases (%)]≤2 pts >2 pts ≥2b <2b
Treatment 
(n=20)
13(65.00) 7(35.00) 17(85.00) 3(15.00) 2(10.00)
Control 
(n=20)
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（2）MOCA Score Comparison
Table	2. Comparison of each Item in MOCA Scoring
Item Treatment Group Control Group P
Visual Spatial and Execution 2.8±1.0 4.7±0.5 0.00
Naming 2.6±0.5 2.9±0.3 0.14
Concentration 5.1±0.9 5.7±0.5 0.07
Language 2.1±0.7 2.9±0.3 0.01
Abstraction 1.8±0.4 1.8±0.4 1
Delayed Recall 2.9±1.0 4.2±0.6 0.00
Direction 4.8±0.6 5.2±0.8 0.23
MOCA 22.1±2.6 27.4±1.3 0.00
（3）Comparison of Difference in CTP between Groups 
Table	3. Comparison of the CTP in the Mild Stenosis Group
Affected Side Healthy Side P
CBV(m1/100g) 1.33±0.56 2.20±0.97 0.002
CBF(ml/100g/min) 20.17±7.94 30.67±13.39 0.023
TTP(s) 15.68±3.61 14.81±3.76 0.263
MTT(s) 3.58±0.78 3.52±1.04 0.842
Table	4. The Comparison of CTP in the Moderate Steno-
sis Group
Affected Side Healthy Side P
CBV(m1/100g) 1.17±0.68 1.85±1.15 0.011
CBF(ml/100g/min) 16.57±9.13 24.06±14.62 0.054
TTP(s) 16.55±5.81 12.54±2.46 0.003
MTT(s) 3.81±0.84 2.89±0.51 0.005
（4）Comparison of Difference in ReHo Value be-
tween Groups









-Left Central Frontal 
Gyrus
6 -53 -12 64 -12.87 54
Left Frontal Gyrus 10 -15 55 12 -15.77 46
Lingual Gyrus of 
Right Occipital Lobe
17 12 -89 -3 -13.23 28
Lingual Gyrus of 
Left Occipital Lobe
17 -9 -89 0 -13.33 30
Left Middle 
Temporal Gyrus
21 -54 1 -19 -9.40 18
Left Precuneus 39 33 -65 36 -22.64 28
Left Posterior 
Cerebellum
- -27 -69 -21 -34.06 48
Right Anterior 
Cerebellum
- 28 -37 -36 -11.46 31
Right Posterior 
Cerebellum
- 28 -80 42 -13.70 28
Table	6. Regions with Significant Drop in ReHo Value in 
the Control Group ReHo







6 -6 -9 61 9.93 36
Right Superior 
Temporal Gyrus
22 51 -18 0 27.75 33
Right Superior 
Temporal Gyrus
38 45 16 -27 21.29 29
Left 
Hippocampus
- -19 -14 -24 18.89 38
4. Discussions
At this stage, patients with severe middle cerebral 
artery stenosis or occlusion have mainly three treatment 
options: endovascular treatment, surgical treatment and 
medical drug treatment. In recent years, with the devel-
opment of endovascular treatment technology, continuous 
improvement of interventional devices and improvement 
of operational proficiency, the status of endovascular treat-
ment in the middle cerebral artery is being valued by more 
and more scholars [2]. However, there are not many stud-
ies on the intravascular treatment of the middle cerebral 
artery. The follow-up time is short, so the patients’ long-
term patency is not clear, and the long-term follow-up of 
hemodynamics is insufficient, especially the cognitive 
dysfunction is rarely assessed in some patients. Experi-
mental and clinical studies have shown that for mild to 
moderate middle cerebral artery stenosis, the use of drug 
therapy and stenting can improve cognitive function; for 
severe middle cerebral artery stenosis or even occlusion, 
drug treatment cannot improve the cognitive function. 
However, interventional therapy can significantly improve 
intracranial blood supply, thereby improving human cog-
nitive function. After patients with severe middle cerebral 
artery stenosis or occlusion underwent endovascular treat-
ment, their executive and memory ability may be signifi-
cantly improved [3].
Vascular cognitive impairment refers to cognitive im-
pairment syndrome, which ranges from mild cognitive 
impairment to dementia caused by cerebrovascular inci-
dents. In many studies, the detection sensitivity of MOCA 
for mild vascular cognitive impairment is much higher 
than that of MMSE, which helps in the early diagnosis of 
vascular cognitive impairment and prevent vascular de-
mentia in time. Therefore, in this study, we used the Mon-
treal Cognitive Assessment Scale to assess the cognitive 
function of the subjects. The Montreal Assessment Scale 
showed that there were significant differences in visual 
spatial, executive function, language and delayed recall 
DOI: https://doi.org/10.30564/jams.v4i2.3339
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between the treatment group and the control group, but the 
two groups had no significant difference in naming, con-
centration, abstraction and direction [4]. In this study, cen-
tral arteriovenous occlusion was assigned as the treatment 
group and endovascular treatment was performed. The 
blood flow of the middle cerebral artery was improved, 
but the patients' left-side visual spatial, executive, lan-
guage and memory dysfunction, and concentration were 
not significantly different from those of the control group. 
Therefore, in this study, we found that patients with acute 
central arteriovenous occlusion have been successfully 
treated and recovered. Although they still have cognitive 
impairment, their concentration has been improved.
Current research shows that cerebral hemodynamic 
diseases caused by cerebral artery stenosis can be di-
vided into four stages; stage 0 means that cerebral he-
modynamics is completely normal; stage 1 means that 
as the cerebral perfusion pressure decreases, the body 
performs differently in level of actions. Cerebrovascular 
self-regulation dilates cerebral arterioles to reduce vas-
cular resistance, and then reduce the ability of normal 
CBF by maintaining brain tissue, but at the expense of 
cerebrovascular reserve and CVR; the second stage is 
the further reduction of cerebral perfusion pressure. The 
cerebrovascular bed has reached the maximum expansion 
state, but the self-regulation ability of the cerebrovascular 
still cannot maintain the normal CBF of the brain tissue, 
and it is accompanied by the reduction in CBF and CVR 
failure. However, at this stage, the normal metabolism 
of brain tissue can be maintained by increasing oxygen 
intake. In the third stage, the oxygen uptake could not be 
maintained, but the decreased cerebral blood flow showed 
that it could not meet the continuous decrease of cerebral 
perfusion pressure of normal brain tissue.
Cognitive function is a complex high-level brain func-
tion activity, accomplished not through a single brain 
area or neural structure but through multiple brain func-
tional areas and neural structures [5]. Studies have shown 
that memory functions involve many cortex and cortical 
structures. When brain damage occurs, the frontal lobe, 
temporal lobe, hippocampus, target gyrus, thalamus and 
midbrain reticular structure may further reduce [6]. An-
other study showed that the visual spatial function is ac-
complished by the frontal, temporal, parietal and occipital 
lobes, thalamus, basal ganglia and cerebellum in the two 
cerebral hemispheres [7]. The results of this study show 
that middle cerebral artery infarction can impair visual 
spatial, executive, language and memory functions, and it 
supports cortical and subcortical structures to participate 
in related cognitive activities through specific neural net-
works or circuits formed. Cerebral artery infarction can 
cause cognitive impairment in multiple areas [8].
Secondly, there is little difference in the good prognosis of 
neurological function between the two groups in this study, 
which may be affected by the sample size. Due to the rela-
tively small sample size, the difference is unclear, but it can 
be seen that the endovascular treatment group has a higher 
good prognosis than the non-vascular treatment group. The 
study found that the speech score of the treatment group was 
lower compared with the control group, which indicates that 
patients receiving endovascular treatment and those who 
have recovered from acute middle cerebral artery occlusion 
still have language disorders.
5. Conclusions
There is no obvious breakthrough in the treatment 
of acute middle cerebral artery occlusion and ischemic 
stroke, and the clinical prognosis of patients after medica-
tion is often not ideal. Therefore, in the real world, many 
neurologists perform endovascular treatment on these 
patients according to the guidelines, and the results are 
mixed. Among them, patients with middle cerebral artery 
occlusion recovered well after endovascular treatment, 
but their cognitive function was significantly lower than 
that of the control group. The two groups had significant 
differences in visual space, executive function, language 
and delayed recall, but no significant differences in nam-
ing, concentration, and direction. Compared with previous 
studies, the concentration of patients with acute middle 
cerebral artery occlusion who were successfully treated 
and recovered has improved. The functional strength of 
patients with middle cerebral artery occlusion after end-
ovascular treatment is different from that of the control 
group.
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